Latest Oncology Stories
Aldoxorubicin Showed 66% Complete or Partial Responses and No Tumor Progression in KS Patients with Excellent Tolerability LOS ANGELES, Jan.
A special one-day track for non-clinically licensed oncology patient navigators will be offered at the Academy of Oncology Nurse & Patient Navigators’ (AONN+) Sixth Annual Navigation and
Susan G. Komen® Central and Northern Arizona (Komen CAN AZ) will tackle breast cancer by raffling two tickets for the Big Game occurring in Glendale, Arizona on February 1, 2015.
The Mesothelioma Victims Center is launching a new campaign focused on providing instant access to the nation's best mesothelioma compensation lawyers for all US Navy Veterans exposed to asbestos while
- Discuss interim results for Study 202 evaluating PEGPH20 with gemcitabine and ABRAXANE® in pancreatic cancer patients - SAN DIEGO, Jan.
- A morbid dread of being buried alive. Also spelled 'taphiphobia'.